256 related articles for article (PubMed ID: 23246245)
21. Variable individual sensitivity to cannabis in patients with schizophrenia.
Goldberger C; Dervaux A; Gourion D; Bourdel MC; Lôo H; Laqueille X; Krebs MO
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1145-54. PubMed ID: 20529414
[TBL] [Abstract][Full Text] [Related]
22. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis.
Rabin RA; Zakzanis KK; George TP
Schizophr Res; 2011 May; 128(1-3):111-6. PubMed ID: 21420282
[TBL] [Abstract][Full Text] [Related]
23. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
[TBL] [Abstract][Full Text] [Related]
24. Cognitive measures in long-term cannabis users.
Pope HG; Gruber AJ; Hudson JI; Huestis MA; Yurgelun-Todd D
J Clin Pharmacol; 2002 Nov; 42(S1):41S-47S. PubMed ID: 12412835
[TBL] [Abstract][Full Text] [Related]
25. Neurocognitive functions of heavy cannabis using schizophrenia patients.
Lev-Ran S; Segev A; Braw Y; Levkovitz Y
Eur Psychiatry; 2012 Jul; 27(5):365-8. PubMed ID: 21704501
[TBL] [Abstract][Full Text] [Related]
26. Cannabis Use Characteristics Associated with Self-Reported Cognitive Function in a Nationally Representative U.S. sample.
Rubin-Kahana DS; Butler K; Hassan AN; Sanches M; Le Foll B
Subst Use Misuse; 2024; 59(9):1303-1312. PubMed ID: 38664196
[TBL] [Abstract][Full Text] [Related]
27. Cannabis use and cognitive function: 8-year trajectory in a young adult cohort.
Tait RJ; Mackinnon A; Christensen H
Addiction; 2011 Dec; 106(12):2195-203. PubMed ID: 21749524
[TBL] [Abstract][Full Text] [Related]
28. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
[TBL] [Abstract][Full Text] [Related]
29. Neurological soft signs in non-psychotic patients with cannabis dependence.
Dervaux A; Bourdel MC; Laqueille X; Krebs MO
Addict Biol; 2013 Mar; 18(2):214-21. PubMed ID: 21054691
[TBL] [Abstract][Full Text] [Related]
30. Cannabis dependence, cognitive control and attentional bias for cannabis words.
Cousijn J; Watson P; Koenders L; Vingerhoets WA; Goudriaan AE; Wiers RW
Addict Behav; 2013 Dec; 38(12):2825-32. PubMed ID: 24018225
[TBL] [Abstract][Full Text] [Related]
31. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
32. The effects of cannabis on information-processing speed.
Kelleher LM; Stough C; Sergejew AA; Rolfe T
Addict Behav; 2004 Aug; 29(6):1213-9. PubMed ID: 15236825
[TBL] [Abstract][Full Text] [Related]
33. Relationships between cognitive deficits, symptoms and quality of life in schizophrenia.
Savilla K; Kettler L; Galletly C
Aust N Z J Psychiatry; 2008 Jun; 42(6):496-504. PubMed ID: 18465376
[TBL] [Abstract][Full Text] [Related]
34. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users.
Ramaekers JG; Kauert G; Theunissen EL; Toennes SW; Moeller MR
J Psychopharmacol; 2009 May; 23(3):266-77. PubMed ID: 18719045
[TBL] [Abstract][Full Text] [Related]
35. Adverse effects of cannabis.
Prescrire Int; 2011 Jan; 20(112):18-23. PubMed ID: 21462790
[TBL] [Abstract][Full Text] [Related]
36. Executive function deficits in short-term abstinent cannabis users.
McHale S; Hunt N
Hum Psychopharmacol; 2008 Jul; 23(5):409-15. PubMed ID: 18421794
[TBL] [Abstract][Full Text] [Related]
37. Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study.
van Dijk D; Koeter MW; Hijman R; Kahn RS; van den Brink W
Schizophr Res; 2012 May; 137(1-3):50-7. PubMed ID: 22313726
[TBL] [Abstract][Full Text] [Related]
38. The positive link between executive function and lifetime cannabis use in schizophrenia is not explained by current levels of superior social cognition.
Helle S; Løberg EM; Gjestad R; Schnakenberg Martin AM; Lysaker PH
Psychiatry Res; 2017 Apr; 250():92-98. PubMed ID: 28152399
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoids and psychosis.
Sewell RA; Ranganathan M; D'Souza DC
Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
[TBL] [Abstract][Full Text] [Related]
40. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
Polgár P
Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
